Login to Your Account

Other News To Note

Tuesday, September 20, 2011
RNL BIO Co. Ltd., of Germantown, Md., said its scientists collaborated with Samsung Bioscience Research Institute of Samsung Medical Center in Seoul, Korea, on a preclinical study using fat-derived adult stem cells to treat systemic lupus erythematosus (SLE).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription